CD209, CD209 molecule, 30835

N. diseases: 57; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.060 Biomarker disease BEFREE DC-SIGN promoter SNPs correlated with risk of HCV acquisition via sexual but not IDU exposure, likely through modulation of mRNA expression levels. 29140443 2018
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.060 GeneticVariation disease BEFREE In conclusion, CD209 polymorphisms could play a role in the susceptibility to HCV infection as well as interferon treatment response in our study population from North-East of Italy. 27348632 2016
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.060 GeneticVariation disease BEFREE The objective of this study is to evaluate the association of CD209 promoter haplotypes with risk of HIV-1 infection in a cohort of Spanish male intravenous drug users (IDU) infected with hepatitis C virus (HCV) and to characterize the phenotypic effects of the associated variants. 27539513 2016
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.060 GeneticVariation disease BEFREE Previously the severity and outcome of dengue fever and hepatitis C (diseases caused by viruses from the family Flaviviridae) were associated with the rs4804803 single nucleotide polymorphism (SNP) located in the promoter region of the human CD209 gene. 22061615 2012
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.060 Biomarker disease BEFREE Because CD209 binds hepatitis C virus (HCV) glycoprotein-E2, we investigated this SNP in the context of chronic HCV infection. 20470843 2010
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.060 AlteredExpression disease LHGDN L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. 15371595 2004